glp-1/gcgr dual agonist Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes - Araki - 2022 - Journal of Diabetes Investigation Strategic Design of Triple GLP-1R/GCGR/GIPR
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1




01163-7/asset/e2dcb6d3-462b-4d65-88e0-ea3cc5eaf66c/main.assets/gr3_lrg.jpg)





01022-6/asset/3f55ea20-b36b-4e11-88e9-940a60e8677e/main.assets/gr2_lrg.jpg)














